Azithromycin 250 mg (generic Zithromax, Z-Pak) Pharmacologic Category: Antibiotic, Macrolide FDA-Approved Uses: Community-acquired pneumonia, mild severity Acute Pharyngitis, Group A streptococcus (strep throat) Acute bacterial sinusitis (sinus infection) Acute otitis media (inner ear infection) Acute bacterial exacerbations of chronic obstructive pulmonary disease (COPD) Uncomplicated skin infections Urethritis and cervicitis (caused by Chlamydia trachomatis) Common Off-Label Uses: Babesiosis (malaria-like parasitic disease) Bartonella (cat scratch disease) Infectious traveler's diarrhea Pertussis (whooping cough) Bronchiectasis Typical Adult Dosing: Community-acquired pneumonia, mild severity: Take Azithromycin 500 mg (2 tablets) by mouth DAILY on day 1, then 250 mg (1 tablet) by mouth DAILY on days 2-5orTake Azithromycin 500 mg (2 tablets) by mouth DAILY for 3 days Infectious traveler's diarrhea: Take Azithromycin 500 mg (2 tablets) by mouth DAILY for 3 days Viral upper respiratory infection, Bronchitis, Pertussis: Take Azithromycin 500 mg (2 tablets) by mouth DAILY on day 1, then 250 mg (1 tablet) by mouth DAILY on days 2-5 Sexual transmitted infection (STI), chlamydia: Take Azithromycin 1,000 mg (4 tablets) by mouth ONE TIME, repeat after 1 week if needed Acute bacterial pharyngitis, Sinusitis, Tonsillitis: Take Azithromycin 500 mg (2 tablets) by mouth DAILY on day 1, then 250 mg (1 tablet) by mouth DAILY on days 2-5 Babesiosis, Bartonella: Take Azithromycin 500 mg (2 tablets) by mouth DAILY on day 1, then 250 mg (1 tablet) by mouth DAILY on days 2-5 Pregnancy: Pregnancy Risk Category B (see Appendix A)
The cjc ipa peptides keep natural pulsatile GH patterns because both have relatively short half-lives, creating discrete pulses of GH rise rather than constant levels, which helps preserve receptor response and avoid desensitization
For employers, IVF coverage is a high-signal benefit: it communicates investment in the full arc of an employees family life, not just the period after a child arrives
IGF-1 functions by binding to the IGF-1 receptor (IGF1R) on muscle and tissue cells
What does the glucagon receptor do in retatrutide
View Article European Journal of Endocrinology (1995) "Comparison of the growth hormone-releasing activity of GHRP-2 and GHRP-6." View Article
